CellCap awarded Technology Strategy Board grant to develop a revolutionary blood test for Alzheimer's disease

Posted on
16 June 2014

David Willetts today used his speech at Bournemouth University to announce £48 million of new investment in Biomedical research.

More than 70 cutting edge research projects have been chosen in the latest stage of Biomedical Catalyst funding. They include a revolutionary blood test to identify Alzheimer’s, a potential new gene therapy for Parkinson’s Disease, a new approach for treating cancerous tumours, and a wearable blanket providing light therapy for jaundiced newborns or conditions such as psoriasis.

The full press release can be found here

CellCap technologist wins Bionow award.

Posted on
30 Nov 2012

Bionow have announced the winners of the 2012 Bionow Annual Awards. The winners were presented at the Bionow Annual Awards Dinner which took place on 29th November 2012 at The Mere Golf Resort and Spa.

Promising Technologist of the Year – Sponsored by Novartis Vaccines and Diagnostics Winner: Dr Nick Bryan, CellCap Technologies Ltd.

 Continue Reading »

MoD spin-out receives funding to adapt CellCap's technology into a product that promises improved detection and treatment of cancer.

Posted on
29 Nov 2012

ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl), today announces a £482k award from the National Institute for Health Research (NIHR) Invention for Innovation (i4i) programme to apply its technology to improve the detection of cancer and monitor its change during treatment. Continue Reading »

Top UK health technology companies prepare for business mission in Boston

Posted on
19 Sep 2012

20 of the UK's top health technology businesses will be awarded their place on the Future Health Mission to Boston. There they will benefit from a packed agenda of investor, supply chain partner and customer meetings, and networking opportunities. Continue Reading »

Stem Cell Company receives £75,000 investment from The North West Fund for Biomedical

Posted on
12 Jul 2012

Medical company CellCap Technologies Ltd has received a £75,000 Pathfinder investment from The North West Fund for Biomedical, managed by Spark Impact. Continue Reading »